Literature DB >> 9082298

[Hip ultrasonography. Basic principles and current aspects].

R Graf1.   

Abstract

Hip sonography is the subject of controversial discussion in several countries. This is because of the different demands made on the diagnosis. In principle the techniques described by Harke, Terjesen and Suzuki are satisfied by a differentiation of luxation from non-luxated joints. An evaluation of the hyalin cartilaginous preformed acetabular roof does not exist. Physiological variations dependent on age cannot be differentiated from real dysplasias by the techniques mentioned above. The sonographic examination technique in German-speaking countries evaluates the maturation of the joint and quantifies the cartilage and the bony acetabular roof. Additionally, this coverage is seen in relation to the age, and the deformation of the acetabulum in luxated joints is analysed. Physiological elastic deflection of the hyalin cartilaginous part of the acetabulum can be separated from real instability signs. Oblique positions of the probe during examination of the baby can lead to diagnostic errors, so special examination techniques have to be used. 3D-sonograms may improve the diagnostic possibilities. A general screening of newborns in use in Austria since 1992 has demonstrated that the rate of treatment can be decreased by about 50% and sonography, used correctly, can avoid overtreatment.

Entities:  

Mesh:

Year:  1997        PMID: 9082298     DOI: 10.1007/s001320050065

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  9 in total

1.  Low incidence of early developmental dysplasia of the hip in universal ultrasonographic screening of newborns: analysis and evaluation of risk factors.

Authors:  Alexander Kolb; Nina Schweiger; Mariella Mailath-Pokorny; Alexandra Kaider; Gerhard Hobusch; Catharina Chiari; Reinhard Windhager
Journal:  Int Orthop       Date:  2015-05-05       Impact factor: 3.075

2.  Diagnosing developmental dysplasia of the hip using the Graf ultrasound method: risk and protective factor analysis in 11,820 universally screened newborns.

Authors:  Mohammad Schams; Rob Labruyère; Anne Zuse; Mikolaj Walensi
Journal:  Eur J Pediatr       Date:  2017-07-17       Impact factor: 3.183

3.  Measurement considerations on examiner-dependent factors in the ultrasound assessment of developmental dysplasia of the hip.

Authors:  Alexander Kolb; Emir Benca; Madeleine Willegger; Stephan E Puchner; Reinhard Windhager; Catharina Chiari
Journal:  Int Orthop       Date:  2017-04-12       Impact factor: 3.075

4.  [Congenital hip dysplasia, screening and therapy].

Authors:  A Kolb; R Windhager; C Chiari
Journal:  Orthopade       Date:  2015-11       Impact factor: 1.087

5.  [Paediatric hip sonography: current status at German university hospitals].

Authors:  C-D Peterlein; S Fuchs-Winkelmann
Journal:  Orthopade       Date:  2014-02       Impact factor: 1.087

6.  [The natural history of developmental dysplasia of the hip. A meta-analysis of the published literature].

Authors:  J Ziegler; F Thielemann; C Mayer-Athenstaedt; K-P Günther
Journal:  Orthopade       Date:  2008-06       Impact factor: 1.087

7.  Reproducibility of different screening classifications in ultrasonography of the newborn hip.

Authors:  Christian D Peterlein; Karl F Schüttler; Stefan Lakemeier; Nina Timmesfeld; Christian Görg; Susanne Fuchs-Winkelmann; Markus D Schofer
Journal:  BMC Pediatr       Date:  2010-12-24       Impact factor: 2.125

8.  Obstacles to reduction in infantile developmental dysplasia of the hip.

Authors:  K Studer; N Williams; P Studer; M Baker; A Glynn; B K Foster; P J Cundy
Journal:  J Child Orthop       Date:  2017-10-01       Impact factor: 1.548

9.  Development of an electronic navigation system for elimination of examiner-dependent factors in the ultrasound screening for developmental dysplasia of the hip in newborns.

Authors:  Alexander Kolb; Catharina Chiari; Markus Schreiner; Stephan Heisinger; Madeleine Willegger; Gregor Rettl; Reinhard Windhager
Journal:  Sci Rep       Date:  2020-10-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.